Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Equity Average: 2018-2021

Historic Equity Average for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $205.0 million.

  • Cogent Biosciences' Equity Average rose 14080.29% to $205.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $205.0 million, marking a year-over-year increase of 14080.29%. This contributed to the annual value of $133.2 million for FY2020, which is 189.61% up from last year.
  • Per Cogent Biosciences' latest filing, its Equity Average stood at $205.0 million for Q3 2021, which was down 6.72% from $219.8 million recorded in Q2 2021.
  • In the past 5 years, Cogent Biosciences' Equity Average ranged from a high of $230.7 million in Q1 2021 and a low of -$55.1 million during Q1 2018.
  • For the 3-year period, Cogent Biosciences' Equity Average averaged around $88.7 million, with its median value being $44.5 million (2019).
  • Per our database at Business Quant, Cogent Biosciences' Equity Average crashed by 104.29% in 2020 and then soared by 14,080.29% in 2021.
  • Cogent Biosciences' Equity Average (Quarterly) stood at $63.9 million in 2018, then crashed by 52.74% to $30.2 million in 2019, then soared by 251.90% to $106.2 million in 2020, then skyrocketed by 14,080.29% to $205.0 million in 2021.
  • Its Equity Average stands at $205.0 million for Q3 2021, versus $219.8 million for Q2 2021 and $230.7 million for Q1 2021.